Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world?

Aliment Pharmacol Ther. 2020 Jun;51(11):1199-1200. doi: 10.1111/apt.15714.

Authors

Rebecca Harris^{1

2}, Joe West^{1

3}, Joanne R Morling^{1

3}

Affiliations

¹ NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
² Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
³ Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, City Hospital, Nottingham, UK.

PMID: 32424922
DOI: 10.1111/apt.15714

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Aged
Disease Progression
Humans
Liver Cirrhosis
Medicare
Non-alcoholic Fatty Liver Disease*
United States

Grants and funding

MR/P008348/1/MRC_/Medical Research Council/United Kingdom